What are the public health effects of direct-to-consumer drug advertising?
What are the public health effects of direct-to-consumer drug advertising?
复制标题
DOI：
10.1371/journal.pmed.0030145
复制
发表时间：
2006-03
期刊：
影响因子：
15.8
通讯作者：
Mansfield PR
中科院分区：
文献类型：
--
作者：
Almasi EA;Stafford RS;Kravitz RL;Mansfield PR
辩论背景：只有两个工业化国家，美国和新西兰，允许处方药的直接面向消费者广告（DTCA），尽管新西兰正计划禁止[]。这些政府面临的挑战是确保DTCA利大于弊。DTCA的支持者认为，它有助于告知公众现有的治疗方法，并刺激对高优先级疾病（如缺血性心脏病患者使用他汀类药物）的适当使用。批评者认为，广告中的信息往往是有偏见和误导性的，而且在没有健康益处的净证据的情况下，DTCA提高了处方成本。这种广告的支持者说，它告知公众并刺激药物的适当使用，但批评者认为，广告具有误导性，并在没有健康益处的净证据的情况下提高了处方成本。
Background to the debate: Only two industrialized countries, the United States and New Zealand, allow direct-to-consumer advertising (DTCA) of prescription medicines, although New Zealand is planning a ban [ ]. The challenge for these governments is ensuring that DTCA is more beneficial than harmful. Proponents of DTCA argue that it helps to inform the public about available treatments and stimulates appropriate use of drugs for high-priority illnesses (such as statin use in people with ischemic heart disease). Critics argue that the information in the adverts is often biased and misleading, and that DTCA raises prescribing costs without net evidence of health benefits. Proponents of such advertising say that it informs the public and stimulates appropriate use of drugs, but critics argue that the adverts are misleading and raise prescribing costs without net evidence of health benefits.
登录
查看更多内容
影响因子：
2.4
作者：
Mansfield, Peter R
通讯作者：
Mansfield, Peter R
影响因子：
3.2
作者：
Marchesiello, Patrick;McWilliams, James C.;Shchepetkin, Alexander
通讯作者：
Shchepetkin, Alexander
DOI：
10.3122/jabfm.16.6.513
发表时间：
2003-11-01
期刊：
JOURNAL OF THE AMERICAN BOARD OF FAMILY PRACTICE
影响因子：
--
作者：
Murray, E;Lo, B;Donelan, K
通讯作者：
Donelan, K
影响因子：
120.7
作者：
Lasser, KE;Allen, PD;Bor, DH
通讯作者：
Bor, DH
影响因子：
--
作者：
Moynihan, R;Heath, I;Henry, D
通讯作者：
Henry, D